Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.88. Xtant Medical shares last traded at $0.84, with a volume of 74,084 shares changing hands.

Xtant Medical Trading Up 6.7 %

The company has a quick ratio of 1.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.34.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its position in Xtant Medical by 156.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 33,176 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 20,253 shares in the last quarter. Sterling Investment Advisors Ltd. bought a new stake in shares of Xtant Medical in the 3rd quarter worth approximately $38,000. Northern Trust Corp boosted its position in shares of Xtant Medical by 38.3% in the 4th quarter. Northern Trust Corp now owns 58,666 shares of the medical device company’s stock worth $66,000 after purchasing an additional 16,257 shares in the last quarter. Citadel Advisors LLC boosted its position in shares of Xtant Medical by 88.5% in the 4th quarter. Citadel Advisors LLC now owns 59,866 shares of the medical device company’s stock worth $68,000 after purchasing an additional 28,105 shares in the last quarter. Finally, Bridgeway Capital Management LLC boosted its position in shares of Xtant Medical by 118.7% in the 4th quarter. Bridgeway Capital Management LLC now owns 368,500 shares of the medical device company’s stock worth $416,000 after purchasing an additional 200,000 shares in the last quarter. Hedge funds and other institutional investors own 69.33% of the company’s stock.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix.